Project
Abbvie M14-423 An Open Label, Multicenter Study to Evaluate Long-Term Outcomes With ABT-450/Ritonavir/ABT-267 and ABT-333 With or Without Ribavirin in Adults With Genotyp 1 Chronic Hepatitis C Infection
Automatically Closed · 2015 until 2020
Semela David, Bernsmeier Christine, Künzler-Heule Patrizia, Stillhard Roman
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2015
End Date
2020
Financing
Industry